Investment Themes
Where ChaosBio looks for opportunity.
Six areas of early-stage life sciences, each read through the same risk-reduction lens and a pharmaceutical R&D operator's perspective.
Therapeutics
Small molecules, biologics, and advanced therapy medicinal products (ATMPs) targeting diseases with high unmet medical need.
Explore Therapeutics →Medical Devices
Devices that improve patient outcomes or create a new standard of care, from diagnostics-adjacent hardware to implantables and surgical tools.
Explore Medical Devices →Digital Health
AI and digital solutions that address a clear clinical, workflow, or patient-adoption problem, evaluated past the label to what the software actually does.
Explore Digital Health →Diagnostics
Tools that detect, characterize, or monitor disease — evaluated on analytical validity, clinical validity, and the harder question of clinical utility.
Explore Diagnostics →Life Science Tools
Research platforms, laboratory automation, and the software and hardware that make drug discovery and development faster, cheaper, or more reliable.
Explore Life Science Tools →Biomanufacturing Infrastructure
CMC, process development, and the manufacturing platforms that determine whether a promising therapeutic or biologic can actually be produced at scale.
Explore Biomanufacturing →See opportunities as they come in.
Join the Investor Network to receive curated opportunities across these themes, reviewed through the ChaosBio investment framework.